OCGN

Ocugen, Inc. - Common Stock (OCGN)

About Ocugen, Inc. - Common Stock (OCGN)

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Details

Daily high

$1.08

Daily low

$1.00

Price at open

52 Week High

$2.72

52 Week Low

$0.97

Market cap

359.5M

Dividend yield

Volume

5,507

Avg. volume

7.9M

P/E ratio

-4.16

Ocugen, Inc. - Common Stock News